Goldman Sachs’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,300
| Closed | -$405K | – | 6071 |
|
|
2023
Q2 | $405K | Buy |
+10,300
| New | +$364K | ﹤0.01% | 4850 |
|
|
2017
Q2 | – | Sell |
-50,000
| Closed | -$183K | – | 7039 |
|
|
2017
Q1 | $183K | Buy |
50,000
+49,000
| +4,900% | +$207K | ﹤0.01% | 5781 |
|
|
2016
Q4 | $5K | Sell |
1,000
-28,000
| -97% | -$831K | ﹤0.01% | 6818 |
|
|
2016
Q3 | $1.34M | Sell |
29,000
-3,500
| -11% | -$197K | ﹤0.01% | 4145 |
|
|
2016
Q2 | $1.66M | Sell |
32,500
-29,100
| -47% | -$1.45M | ﹤0.01% | 3769 |
|
|
2016
Q1 | $2.6M | Buy |
61,600
+11,600
| +23% | +$591K | ﹤0.01% | 3246 |
|
|
2015
Q4 | $3.93M | Hold |
50,000
| – | – | ﹤0.01% | 3058 |
|
|
2015
Q3 | $2.03M | Buy |
+50,000
| New | +$2.65M | ﹤0.01% | 3785 |
|
|
2015
Q1 | – | Sell |
-40,000
| Closed | -$1.79M | – | 7347 |
|
|
2014
Q4 | $1.79M | Buy |
+40,000
| New | +$1.68M | ﹤0.01% | 3957 |
|
|
2014
Q2 | – | Sell |
-50,000
| Closed | -$1.78M | – | 7187 |
|
|
2014
Q1 | $1.78M | Buy |
+50,000
| New | +$1.69M | ﹤0.01% | 4085 |
|